Expert insights. Personalized for you.
The post CVS Ignores DEA, Says It’s Already Selling CBD Products appeared first on Leafly. Industry Politics cannabidiol cbd DEA FDAThe nation's largest drugstore chain is selling CBD products in 8 states. Meanwhile, independent CBD stores are being raided by police in Texas. MORE
As a result, the DEA has been encouraged for over a decade to expand the pool of federally licensed cannabis producers — a move that the agency has largely resisted. To date, however, the DEA has failed to either affirm or reject any of the more than 30 applications it has received. MORE
According to figures published in the DEA’s Domestic Cannabis Eradication/Suppression Statistical Report , the agency and its law enforcement partners confiscated an estimated four million marijuana plants in 2019 – up from 2.8 In 2011, for instance, the DEA seized over 8.7 MORE
Buzzfeed News first reported that the Department of Justice expanded the Drug Enforcement Administration’s (DEA) jurisdiction in response to these protests. Now, the DEA does not even need to suspect a drug crime has been committed to take action against protesters. MORE
The hemp industry is not the only one that’s pushing back against the Drug Enforcement Administration (DEA)’s hemp Interim Final Rule (the “ Rule ”). If you read this blog, you’ll recall the hemp industry sued the DEA following the release of its Rule in August 2020. MORE
The DEA’s website did not provide a timeline as to when it anticipates finalizing the applicants’ grow authorizations or when it plans to take actions on the dozens of remaining applications that are still pending before the agency. MORE
Rod Kight and Shane Pennington discuss the DEA lawsuit about hemp extracts. As many readers of this blog know, the… Read More. Rod Kight MORE
One could argue at the moment that some US Federal Agencies have employees on the books who could be accused via their behaviour of scamming … Read More. Breaking News MORE
The post DEA Report: Marijuana Seizures at Southern Border Have Fallen Significantly Following Passage of Statewide Legalization Laws appeared first on NORML. LAW ENFORCEMENT DEA Mexico seizures southern border MORE
The hemp has hit the fan…… California’s Bureau of Cannabis Control had refused to give the DEA those documents, arguing in court filings that the … Read More. MORE
The post DEA finally ends fed monopoly on schwaggy research-grade cannabis appeared first on Leafly. Politics cannabis quality cannabis research DEA nida schwagGoodbye, Mississippi ditch weed. Hello, real-world high-quality cannabis. MORE
The post DEA Increases Access to Cannabis for Research Purposes appeared first on Cannabis Central. News Politics Research cannabis research cultivation DEA“Cannabis should remain illegal because more research is needed. MORE
Today, we focus on some of the high-level requirements of the Drug Enforcement Agency (DEA) on clinics and their personnel. In other words, not just anyone can obtain a DEA registration and dispense ketamine. The post Ketamine Clinics and the DEA appeared first on Harris Bricken MORE
Justices for the US Court of Appeals for the District of Columbia denied the petition following a filing by DEA in the Federal Register stating that the agency “intends to promulgate regulations” to review several dozen federal cultivation applications. However, most of those applications have been before DEA for several years, and the agency still has yet to provide any explicit timeline regarding when, if ever it intends to act on them. MORE
The post DEA loosens rules on prescription CBD drug Epidiolex appeared first on Leafly. Prescription CBD tincture Epidiolex is coming to more patients. Cost: $32,500 per year. Health Politics cannabidiol cbd Epidiolex GW Pharma GW Pharmaceuticals MORE
This action by the DEA means researchers will be able to study marijuana from more than one grower. To the extent these MOAs are finalized, DEA anticipates issuing DEA registrations to these manufacturers. Science saves the day. This we know from the COVID-19 vaccine. MORE
Drug Enforcement Administration’s (DEA) refusal to accommodate state and federal right to try laws. US DEA , No. MORE
” To date, however, the agency has neither affirmed or denied any of the 26 applicants that have sought the DEA’s permission for a federal cultivation license. Read NORML’s new op-ed, “Three years ago the DEA said they would remove roadblocks to cannabis research — they still haven’t, here.). “While most states recognize that cannabis has medical value, the DEA says otherwise, pointing to the absence of clinical research. MORE
The US Drug Enforcement Administration (DEA) has once again pledged to take action to better facilitate clinical cannabis research. According to the agency’s filing today in the Federal Register, the DEA “intends to promulgate regulations” to evaluate several dozen applications before it from private entities that wish to cultivate cannabis for FDA-approved research. FDA GOVERNMENT SCIENCE DEA medical research University of Mississippi MORE
On March 23, DEA published a proposed rulemaking —“Controls to Enhance the Cultivation of Marihuana for Research in the United States”—in the Federal Register (85 FR 16292), involving who can grow cannabis in bulk for research purposes. MORE
A vague memory tells us that the DEA were looking for a contractor early 2019 ? The post DEA - We're Still Burnin' Weed first appeared on Cannabis Law Report. What happened to the last contractor. Marijuana Moment has … Read More. MORE
According to a DEA memorandum , the agency requested to expand its policing powers beyond the enforcement of federal drug laws to include the enforcement of “any federal crime committed as a result of protests over the death of George Floyd.” MORE
Two days before a federal court deadline, the DEA says it will do what it said it would do three years ago. The post DEA Says It Will Finally Let Others Grow Research-Grade Cannabis appeared first on Leafly. Politics DEA research MORE
District Court to block the DEA from unlawfully criminalizing hemp production The lawsuit also highlights the DEA’s history of … Read More. The detailed complaint asks a U.S. MORE
Despite mounting evidence into cannabis’ therapeutic benefits, the DEA continues to close its eyes and plug its ears, constantly claiming that there is not enough research to support its medicinal value, according to Marijuana Moment. However, the DEA does not keep its staff employed without drugs to seize, with marijuana being an easy target. It could be argued that the DEA is hesitant for the sake of public safety. Here, DEA can act with little expenditure of resources.”. MORE
20-71433, was an appellate case filed by a group of scientists and veterans that had sued the DEA in May 2020. Congress thus expressly authorized individuals to petition the DEA—not the courts directly—to schedule, reschedule, or remove a substance.”. MORE
The DEA Just Passed a BAD Interim Rule Impacting Hemp CBD and Other Cannabinoids. DEA Interim Final Rule: What Is “Synthetically Derived THC”? The DEA Does Not Want You To Worry About Its New Hemp Rule. The Hemp Industry Responds to the DEA Rule With a Lawsuit. MORE
The DEA now estimates that, under the new rules, it may approve between three and 15 total applicants. In 2016, the DEA publicly announced that it would, for the first time, begin accepting applications from private entities wishing to grow research-grade cannabis. MORE
All that is about to change, thanks to a change at the DEA , which cultivators and industry experts say will be monumental for cannabis research, medical marijuana patients, and potentially the broader legal status of the plant itself. “We MORE
The post DEA Asks Court To Overturn Cannabis Rescheduling Appeal first appeared on Cannabis Law Report. The U.S. MORE
The language is general but it looks like the DEA will be trying to nip supply in the bud at source. As part of the review, the team will talk to DEA personnel posted in DEA’s foreign offices and headquarters who perform this critical work. MORE
Lawyers for the group appealed that decision, asking the court to order DEA to initiate a formal rulemaking process, which would involve expert testimony and public comment. Court Dismisses DEA Marijuana Rescheduling Case, But Judge Says Cannabis Reclassification May Be Coming Anyway. MORE
The Drug Enforcement Administration made a milestone announcement earlier this month with the news that the DEA will begin granting marijuana cultivation licenses to various third-party applicants, significantly expanding medical and scientific cannabis research in the United States. MORE
According to figures published in the DEA’s Domestic Cannabis Eradication/Suppression Statistical Report, the agency and its law enforcement partners confiscated an estimated 2.82 However, while the total number of DEA-seized plants fell in 2018, seizures of indoor cannabis plants nearly doubled – rising from 304,000 plants in 2017 to just under 600,000 in 2018. LAW ENFORCEMENT assets DEA eradication legalization seizures MORE
The Canna Law Blog has been writing about the Drug Enforcement Agency’s (DEA) interim final rule (IFR) on hemp since its August publication in the Federal Register: Watch Out! The DEA Just Passed a BAD Interim Rule Impacting Hemp CBD and Other Cannabinoids. MORE
The post Wasn’t the DEA Going to Let Others Grow Research-Grade Cannabis? Science & Tech DEA nida researchYes, it was. So why has the agency delayed applications? Sue Sisley demands an answer, and the courts agree with her. appeared first on Leafly. MORE
DEA Related Topics 
NORML
MAY 24, 2021
The DEA’s website did not provide a timeline as to when it anticipates finalizing the applicants’ grow authorizations or when it plans to take actions on the dozens of remaining applications that are still pending before the agency.
NORML
APRIL 14, 2020
According to figures published in the DEA’s Domestic Cannabis Eradication/Suppression Statistical Report , the agency and its law enforcement partners confiscated an estimated four million marijuana plants in 2019 – up from 2.8 In 2011, for instance, the DEA seized over 8.7
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
NORML
MARCH 3, 2021
The post DEA Report: Marijuana Seizures at Southern Border Have Fallen Significantly Following Passage of Statewide Legalization Laws appeared first on NORML. LAW ENFORCEMENT DEA Mexico seizures southern border
Leafly
MAY 18, 2021
The post DEA finally ends fed monopoly on schwaggy research-grade cannabis appeared first on Leafly. Politics cannabis quality cannabis research DEA nida schwagGoodbye, Mississippi ditch weed. Hello, real-world high-quality cannabis.
NORML
APRIL 8, 2020
As a result, the DEA has been encouraged for over a decade to expand the pool of federally licensed cannabis producers — a move that the agency has largely resisted. To date, however, the DEA has failed to either affirm or reject any of the more than 30 applications it has received.
Cannabis Law Report
AUGUST 27, 2021
The language is general but it looks like the DEA will be trying to nip supply in the bud at source. As part of the review, the team will talk to DEA personnel posted in DEA’s foreign offices and headquarters who perform this critical work.
Leafly
JUNE 8, 2020
The DEA's five-part test to determine 'currently accepted medical use' is flawed, say the plaintiffs. The post New lawsuit aims to force DEA to reschedule marijuana appeared first on Leafly.
NORML
JULY 16, 2019
According to figures published in the DEA’s Domestic Cannabis Eradication/Suppression Statistical Report, the agency and its law enforcement partners confiscated an estimated 2.82 However, while the total number of DEA-seized plants fell in 2018, seizures of indoor cannabis plants nearly doubled – rising from 304,000 plants in 2017 to just under 600,000 in 2018. LAW ENFORCEMENT assets DEA eradication legalization seizures
NORML
APRIL 13, 2021
The post NORML Comments on Biden’s Pick for DEA Administrator appeared first on NORML. Former NJ Attorney General to be Nominated to Lead Agency. LAW ENFORCEMENT Federal milgram nominee
NORML
AUGUST 26, 2019
The US Drug Enforcement Administration (DEA) has once again pledged to take action to better facilitate clinical cannabis research. According to the agency’s filing today in the Federal Register, the DEA “intends to promulgate regulations” to evaluate several dozen applications before it from private entities that wish to cultivate cannabis for FDA-approved research. FDA GOVERNMENT SCIENCE DEA medical research University of Mississippi
HarrisBricken
SEPTEMBER 3, 2021
20-71433, was an appellate case filed by a group of scientists and veterans that had sued the DEA in May 2020. Congress thus expressly authorized individuals to petition the DEA—not the courts directly—to schedule, reschedule, or remove a substance.”.
|
Canna Law Blog
OCTOBER 17, 2020
The Canna Law Blog has been writing about the Drug Enforcement Agency’s (DEA) interim final rule (IFR) on hemp since its August publication in the Federal Register: Watch Out! The DEA Just Passed a BAD Interim Rule Impacting Hemp CBD and Other Cannabinoids.
Cannabis Law Report
AUGUST 12, 2021
Drug Enforcement Administration’s (DEA) refusal to accommodate state and federal right to try laws. US DEA , No.
Cannabis Law Report
OCTOBER 27, 2020
A vague memory tells us that the DEA were looking for a contractor early 2019 ? The post DEA - We're Still Burnin' Weed first appeared on Cannabis Law Report. What happened to the last contractor. Marijuana Moment has … Read More.
Veriheal
JUNE 22, 2021
The post DEA Increases Access to Cannabis for Research Purposes appeared first on Cannabis Central. News Politics Research cannabis research cultivation DEA“Cannabis should remain illegal because more research is needed.
NORML
JUNE 3, 2020
According to a DEA memorandum , the agency requested to expand its policing powers beyond the enforcement of federal drug laws to include the enforcement of “any federal crime committed as a result of protests over the death of George Floyd.”
Leafly
MARCH 22, 2019
The post CVS Ignores DEA, Says It’s Already Selling CBD Products appeared first on Leafly. Industry Politics cannabidiol cbd DEA FDAThe nation's largest drugstore chain is selling CBD products in 8 states. Meanwhile, independent CBD stores are being raided by police in Texas.
Cannabis Law Report
SEPTEMBER 1, 2021
Lawyers for the group appealed that decision, asking the court to order DEA to initiate a formal rulemaking process, which would involve expert testimony and public comment. Court Dismisses DEA Marijuana Rescheduling Case, But Judge Says Cannabis Reclassification May Be Coming Anyway.
Leafly
AUGUST 26, 2019
Two days before a federal court deadline, the DEA says it will do what it said it would do three years ago. The post DEA Says It Will Finally Let Others Grow Research-Grade Cannabis appeared first on Leafly. Politics DEA research
Cannabis Law Report
MAY 17, 2021
Rod Kight and Shane Pennington discuss the DEA lawsuit about hemp extracts. As many readers of this blog know, the… Read More. Rod Kight
Canna Law Blog
JUNE 17, 2020
Buzzfeed News first reported that the Department of Justice expanded the Drug Enforcement Administration’s (DEA) jurisdiction in response to these protests. Now, the DEA does not even need to suspect a drug crime has been committed to take action against protesters.
Americans for Safe Access
JUNE 2, 2020
On March 23, DEA published a proposed rulemaking —“Controls to Enhance the Cultivation of Marihuana for Research in the United States”—in the Federal Register (85 FR 16292), involving who can grow cannabis in bulk for research purposes.
NORML
OCTOBER 21, 2019
Justices for the US Court of Appeals for the District of Columbia denied the petition following a filing by DEA in the Federal Register stating that the agency “intends to promulgate regulations” to review several dozen federal cultivation applications. However, most of those applications have been before DEA for several years, and the agency still has yet to provide any explicit timeline regarding when, if ever it intends to act on them.
NewsMunchies
MAY 20, 2021
This action by the DEA means researchers will be able to study marijuana from more than one grower. To the extent these MOAs are finalized, DEA anticipates issuing DEA registrations to these manufacturers. Science saves the day. This we know from the COVID-19 vaccine.
Leafly
AUGUST 19, 2019
The post Wasn’t the DEA Going to Let Others Grow Research-Grade Cannabis? Science & Tech DEA nida researchYes, it was. So why has the agency delayed applications? Sue Sisley demands an answer, and the courts agree with her. appeared first on Leafly.
Cannabis Law Report
JULY 29, 2020
One could argue at the moment that some US Federal Agencies have employees on the books who could be accused via their behaviour of scamming … Read More. Breaking News
Cannabis Law Report
DECEMBER 3, 2020
The post DEA Asks Court To Overturn Cannabis Rescheduling Appeal first appeared on Cannabis Law Report. The U.S.
NORML
AUGUST 2, 2019
” To date, however, the agency has neither affirmed or denied any of the 26 applicants that have sought the DEA’s permission for a federal cultivation license. Read NORML’s new op-ed, “Three years ago the DEA said they would remove roadblocks to cannabis research — they still haven’t, here.). “While most states recognize that cannabis has medical value, the DEA says otherwise, pointing to the absence of clinical research.
SpeedWeed
MAY 24, 2021
The Drug Enforcement Administration made a milestone announcement earlier this month with the news that the DEA will begin granting marijuana cultivation licenses to various third-party applicants, significantly expanding medical and scientific cannabis research in the United States.
WeedAdvisor
JULY 4, 2019
Despite mounting evidence into cannabis’ therapeutic benefits, the DEA continues to close its eyes and plug its ears, constantly claiming that there is not enough research to support its medicinal value, according to Marijuana Moment. However, the DEA does not keep its staff employed without drugs to seize, with marijuana being an easy target. It could be argued that the DEA is hesitant for the sake of public safety. Here, DEA can act with little expenditure of resources.”.
Leafly
APRIL 6, 2020
The post DEA loosens rules on prescription CBD drug Epidiolex appeared first on Leafly. Prescription CBD tincture Epidiolex is coming to more patients. Cost: $32,500 per year. Health Politics cannabidiol cbd Epidiolex GW Pharma GW Pharmaceuticals
HarrisBricken
MAY 5, 2021
The DEA Just Passed a BAD Interim Rule Impacting Hemp CBD and Other Cannabinoids. DEA Interim Final Rule: What Is “Synthetically Derived THC”? The DEA Does Not Want You To Worry About Its New Hemp Rule. The Hemp Industry Responds to the DEA Rule With a Lawsuit.
The Cannigma
JUNE 14, 2021
All that is about to change, thanks to a change at the DEA , which cultivators and industry experts say will be monumental for cannabis research, medical marijuana patients, and potentially the broader legal status of the plant itself. “We
Cannabis Law Report
OCTOBER 12, 2020
District Court to block the DEA from unlawfully criminalizing hemp production The lawsuit also highlights the DEA’s history of … Read More. The detailed complaint asks a U.S.
Cannabis Law Report
SEPTEMBER 1, 2020
The hemp has hit the fan…… California’s Bureau of Cannabis Control had refused to give the DEA those documents, arguing in court filings that the … Read More.
Canna Law Blog
OCTOBER 29, 2020
The hemp industry is not the only one that’s pushing back against the Drug Enforcement Administration (DEA)’s hemp Interim Final Rule (the “ Rule ”). If you read this blog, you’ll recall the hemp industry sued the DEA following the release of its Rule in August 2020.
Canna Law Blog
JUNE 11, 2020
Today, we focus on some of the high-level requirements of the Drug Enforcement Agency (DEA) on clinics and their personnel. In other words, not just anyone can obtain a DEA registration and dispense ketamine. The post Ketamine Clinics and the DEA appeared first on Harris Bricken
88 
Let's personalize your content